The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gasmi Mehdi since 2015.
The trader's CIK number is 1614875.
At the time of the last reporting, Gasmi Mehdi was the VP, Pharmaceutical Development of Adverum Biotechnologies, Inc.. (stock ticker symbol ADVM).
Also see all insider trading activities at Adverum Biotechnologies, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ADVM | 0 | $0 | 110,000 | $2,276,476 | 110,000 | $527,998 |
| 2015 | ADVM | 0 | $0 | 15,000 | $575,878 | 15,000 | $41,250 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-20 | ADVM | Option Ex | 5,000 | 4.80 | 24,000 |
| 2020-07-20 | ADVM | Sale | 5,000 | 17.60 | 87,980 |
| 2020-06-22 | ADVM | Sale | 23,605 | 25.06 | 591,612 |
| 2020-06-22 | ADVM | Option Ex | 23,605 | 4.80 | 113,304 |
| 2020-06-17 | ADVM | Sale | 268 | 25.01 | 6,702 |
| 2020-06-18 | ADVM | Sale | 11,127 | 25.01 | 278,330 |
| 2020-06-18 | ADVM | Option Ex | 11,127 | 4.80 | 53,409 |
| 2020-06-17 | ADVM | Option Ex | 268 | 4.80 | 1,286 |
| 2020-06-15 | ADVM | Option Ex | 10,000 | 4.80 | 48,000 |
| 2020-06-15 | ADVM | Sale | 10,000 | 22.38 | 223,830 |
| 2020-05-20 | ADVM | Option Ex | 1,401 | 4.80 | 6,724 |
| 2020-05-21 | ADVM | Sale | 3,599 | 20.02 | 72,048 |
| 2020-05-20 | ADVM | Sale | 1,401 | 20.01 | 28,029 |
| 2020-05-21 | ADVM | Option Ex | 3,599 | 4.80 | 17,275 |
| 2020-05-05 | ADVM | Option Ex | 10,000 | 4.80 | 48,000 |
| 2020-05-06 | ADVM | Option Ex | 25,000 | 4.80 | 120,000 |
| 2020-05-05 | ADVM | Sale | 10,000 | 16.26 | 162,570 |
| 2020-05-18 | ADVM | Option Ex | 5,000 | 4.80 | 24,000 |
| 2020-05-06 | ADVM | Sale | 25,000 | 20.03 | 500,675 |
| 2020-05-18 | ADVM | Sale | 5,000 | 18.57 | 92,855 |
| 2020-02-18 | ADVM | Option Ex | 5,000 | 4.80 | 24,000 |
| 2020-02-18 | ADVM | Sale | 5,000 | 16.23 | 81,155 |
| 2020-02-12 | ADVM | Sale | 10,000 | 15.07 | 150,690 |
| 2020-02-12 | ADVM | Option Ex | 10,000 | 4.80 | 48,000 |
| 2015-06-15 | [AAVL] | Option Ex | 500 | 2.75 | 1,375 |
| 2015-06-15 | [AAVL] | Sale | 500 | 39.86 | 19,931 |
| 2015-06-08 | [AAVL] | Option Ex | 500 | 2.75 | 1,375 |
| 2015-06-08 | [AAVL] | Sale | 500 | 38.93 | 19,467 |
| 2015-05-28 | [AAVL] | Sale | 500 | 38.02 | 19,009 |
| 2015-05-28 | [AAVL] | Option Ex | 500 | 2.75 | 1,375 |
| 2015-05-21 | AAVL | Option Ex | 500 | 2.75 | 1,375 |
| 2015-05-21 | AAVL | Sale | 500 | 38.87 | 19,435 |
| 2015-05-14 | [AAVL] | Sale | 500 | 35.31 | 17,656 |
| 2015-05-14 | [AAVL] | Option Ex | 500 | 2.75 | 1,375 |
| 2015-05-07 | AAVL | Option Ex | 500 | 2.75 | 1,375 |
| 2015-05-07 | AAVL | Sale | 500 | 33.28 | 16,638 |
| 2015-04-28 | AAVL | Option Ex | 1,000 | 2.75 | 2,750 |
| 2015-04-28 | AAVL | Sale | 1,000 | 35.67 | 35,667 |
| 2015-04-21 | AAVL | Option Ex | 1,000 | 2.75 | 2,750 |
| 2015-04-21 | AAVL | Sale | 1,000 | 39.21 | 39,211 |
| 2015-04-14 | AAVL | Option Ex | 1,000 | 2.75 | 2,750 |
| 2015-04-14 | AAVL | Sale | 1,000 | 39.45 | 39,448 |
| 2015-04-07 | AAVL | Sale | 9,000 | 38.82 | 349,416 |
| 2015-04-07 | AAVL | Option Ex | 9,000 | 2.75 | 24,750 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gasmi Mehdi (VP, Pharmaceutical Development of Adverum Biotechnologies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.